Survival Outcomes of Patients With Borderline Resectable and Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Short-Course Chemoradiotherapy With Capecitabine-Based vs. Gemcitabine-Based Concurrent Chemotherapy
| Autor: | Neibart, S.S., Mamidanna, S., Chundury, A., Sayan, M., Alexander, H.R., August, D., Berim, L.D., Boland, P.M., Grandhi, M.S., Gulhati, P., Hochster, H.S., Kennedy, T.J., Langan, R.C., Spencer, K., Jabbour, S.K. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 November 2021 111(3) Supplement:e64-e64 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|